REQUEST A DEMO
Total
USD $0.00
Search more companies

Dori-Darmon Aj (Uzbekistan)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Dori-Darmon Aj Profile Updated: January 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Dori-Darmon Aj is an enterprise based in Uzbekistan. Its main office is in Tashkent. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on April 24, 2026. It currently has a total number of 11 - 50 (2024) employees. There was a net sales revenue drop of 38.63% reported in Dori-Darmon Aj’s latest financial highlights for Q3C2025. Its’ total assets recorded a growth of 2.83%.

Headquarters
21, Akhunbabaev Squire
Tashkent; Tashkent; Postal Code: 100021

Contact Details: Purchase the Dori-Darmon Aj report to view the information.

Website: http://www.doridarmon.uz

Basic Information
Total Employees:
Purchase the Dori-Darmon Aj report to view the information.
Financial Auditors:
Purchase the Dori-Darmon Aj report to view the information.
Incorporation Date:
April 24, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice Chairman
Subsidiaries
Dd General Insurance Ltd
100%
Dori Darmon Invest Ltd
100%
Dori-Darmon Garant Subsidiary
100%
Company Performance
Financial values in the chart are available after Dori-Darmon Aj report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UZS. Absolute financial data is included in the purchased report.
Net sales revenue
-38.63%
Total Operating Revenue
-38.83%
Operating Profit
-123.67%
EBITDA
-123.67%
Net Profit/Loss for the Period
N/A
Total Assets
2.83%
Total Equity
1.25%
Operating Profit Margin
-22.94%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-8.32%
Quick Ratio
0.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?